OR7-1: A reversible albumin-binding GH derivative possesses a promising once-weekly treatment profile and is well tolerated in adult subjects with growth hormone deficiency

M. Højby Rasmussen, J. Janukonyté, M. Klose, D. Marina, M. Tanvig, L.F. Nielsen, C. Höybye, M. Andersen, U. Feldt-Rasmussen, J. Sandahl Christiansen
  • Growth Hormone & IGF Research, October 2014, Elsevier
  • DOI: 10.1016/s1096-6374(14)50047-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Ulla Feldt-Rasmussen